Optimind Pharma Corp. announced that David Goodman, a member of the Company's Board of Directors, assumes the mantle of Chief Executive Officer ("CEO") with a forward-looking vision for Optimind's continued growth and innovation. Former CEO and Director, Tom Sipos, has gracefully stepped down due to personal reasons.

The Company expresses gratitude to Mr. Sipos for his valuable contributions and extends best wishes for his future endeavors.